0000899243-18-029304.txt : 20181119
0000899243-18-029304.hdr.sgml : 20181119
20181119161435
ACCESSION NUMBER: 0000899243-18-029304
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181115
FILED AS OF DATE: 20181119
DATE AS OF CHANGE: 20181119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ganot Ilan
CENTRAL INDEX KEY: 0001727460
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38360
FILM NUMBER: 181192636
MAIL ADDRESS:
STREET 1: C/O SOLID BIOSCIENCES, LLC
STREET 2: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Solid Biosciences Inc.
CENTRAL INDEX KEY: 0001707502
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 900943402
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-337-4682
MAIL ADDRESS:
STREET 1: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Solid Biosciences, LLC
DATE OF NAME CHANGE: 20170524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-15
0
0001707502
Solid Biosciences Inc.
SLDB
0001727460
Ganot Ilan
C/O SOLID BIOSCIENCES INC.
141 PORTLAND STREET, 5TH FLOOR
CAMBRIDGE
MA
02139
1
1
0
0
CEO & President
Common Stock
2018-11-15
4
S
0
30900
30.6995
D
1121226
D
Common Stock
2018-11-15
4
S
0
19100
31.0638
D
1102126
D
Common Stock
290914
I
see footnote
The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.995, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.48, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form.
Represents 1,060,595 shares held by Mr. Ganot as an individual. Represents 60,631 shares held by Mr. Ganot and Ms. Annie Ganot as joint tenants with a right of survivorship.
Represents 1, 041,495 shares held by Mr. Ganot as an individual. Represents 60,631 shares held by Mr. Ganot and Ms. Annie Ganot as joint tenants with a right of survivorship.
Represents 209,914 shares held by Mr. Adam Ganot and Ms. Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
/s/ Ilan Ganot
2018-11-19